MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6

被引：31
作者：
Han, Hye Sook [1 ]
Son, Seung-Myoung [2 ]
Yun, Jieun [3 ]
Jo, Yeong Nang [3 ]
Lee, Ok-Jun [2 ]
机构：
[1] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju 361763, South Korea
[2] Chungbuk Natl Univ, Coll Med, Dept Pathol, Cheongju 361763, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongwon, South Korea
来源：
FEBS LETTERS | 2014年 / 588卷 / 20期
基金：
新加坡国家研究基金会;
关键词：
Carcinoembryonic antigen-related cell; adhesion molecule 6; Lung adenocarcinoma; MicroRNA; 29a; PANCREATIC ADENOCARCINOMA; CEACAM6; CANCER; FAMILY; EXPRESSION; MIR-29; OVEREXPRESSION; DETERMINANT; PROGRESSION; METASTASIS;
D O I：
10.1016/j.febslet.2014.08.023
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is an important regulator of cell adhesion, invasion, and metastasis. The aim of this study was to evaluate the functional roles of CEACAM6 in lung adenocarcinoma and to identify miRNAs that inhibit the growth, migration, and invasion of lung adenocarcinoma cells by targeting CEACAM6. CEACAM6 expression is associated with poor prognosis of patients with lung adenocarcinoma, and CEACAM6 has important functional roles in controlling the growth, migration, and invasion of lung adenocarcinoma cells in vitro and in vivo. Furthermore, miR-29a can suppress the growth, migration, and invasion of lung adenocarcinoma cells by targeting CEACAM6. Therefore, miR-29a/CEACAM6 axis represents a potential therapeutic target for treatment of lung adenocarcinoma. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：3744 / 3750
页数：7
相关论文
共 37 条
  • [11] A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells
    Duxbury, MS
    Ito, H
    Benoit, E
    Waseem, T
    Ashley, SW
    Whang, EE
    [J]. CANCER RESEARCH, 2004, 64 (11) : 3987 - 3993
  • [12] RETRACTED: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells (Retracted article. See FEB, 2023)
    Duxbury, MS
    Ito, H
    Zinner, MJ
    Ashley, SW
    Whang, EE
    [J]. ONCOGENE, 2004, 23 (02) : 465 - 473
  • [13] Non-Small Cell Lung Cancer, Version 2.2013 Featured Updates to the NCCN Guidelines
    Ettinger, David S.
    Akerley, Wallace
    Borghaei, Hossein
    Chang, Andrew C.
    Cheney, Richard T.
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    Demmy, Todd L.
    Govindan, Ramaswamy
    Grannis, Frederic W., Jr.
    Grant, Stefan C.
    Horn, Leora
    Jahan, Thierry M.
    Komaki, Ritsuko
    Kong, Feng-Ming
    Kris, Mark G.
    Krug, Lee M.
    Lackner, Rudy P.
    Lennes, Inga T.
    Loo, Billy W., Jr.
    Martins, Renato
    Otterson, Gregory A.
    Patel, Jyoti D.
    Pinder-Schenck, Mary C.
    Pisters, Katherine M.
    Reckamp, Karen
    Riely, Gregory J.
    Rohren, Eric
    Shapiro, Theresa A.
    Swanson, Scott J.
    Tauer, Kurt
    Wood, Douglas E.
    Yang, Stephen C.
    Gregory, Kristina
    Hughes, Miranda
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (06): : 645 - 653
  • [14] MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
    Fabbri, Muller
    Garzon, Ramiro
    Cimmino, Amelia
    Liu, Zhongfa
    Zanesi, Nicola
    Callegari, Elisa
    Liu, Shujun
    Alder, Hansjuerg
    Costinean, Stefan
    Fernandez-Cymering, Cecilia
    Volinia, Stefano
    Guler, Gulnur
    Morrison, Carl D.
    Chan, Kenneth K.
    Marcucci, Guido
    Calin, George A.
    Huebner, Kay
    Croce, Carlo M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (40) : 15805 - 15810
  • [15] miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis
    Gebeshuber, Christoph A.
    Zatloukal, Kurt
    Martinez, Javier
    [J]. EMBO REPORTS, 2009, 10 (04) : 400 - 405
  • [16] The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
    Goldstraw, Peter
    Crowley, John
    Chansky, Kari
    Giroux, Dorothy J.
    Groome, Patti A.
    Rami-Porta, Ramon
    Postmus, Pieter E.
    Rusch, Valerie
    Sobin, Leslie
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : 706 - 714
  • [17] Hallmarks of Cancer: The Next Generation
    Hanahan, Douglas
    Weinberg, Robert A.
    [J]. CELL, 2011, 144 (05) : 646 - 674
  • [18] HEFTA SA, 1990, J BIOL CHEM, V265, P8618
  • [19] Expression of CEACAM6 in resectable colorectal cancer:: A factor of independent prognostic significance
    Jantscheff, P
    Terracciano, L
    Lowy, A
    Glatz-Krieger, K
    Grunert, F
    Micheel, B
    Brümmer, J
    Laffer, U
    Metzger, U
    Herrmann, R
    Rochlitz, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3638 - 3646
  • [20] Diverse roles of miR-29 in cancer (Review)
    Jiang, Hesong
    Zhang, Guang
    Wu, Jun-Hua
    Jiang, Chun-Ping
    [J]. ONCOLOGY REPORTS, 2014, 31 (04) : 1509 - 1516
1234